Skip to content

Clinical trials

Recruiting Observational Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Observational Status: Recruiting Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20171
20191
20201
20211
20232
20242
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
European Institute of Oncology2
Astellas Pharma Korea, Inc.1
Carol Davila University of Medicine and Pharmacy1
Centre Hospitalier Universitaire de Saint Etienne1
Dutch Society of Physicians for Pulmonology and Tuberculosis1
Heinrich-Heine University, Duesseldorf1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Institute of Cancer Research, United Kingdom1
Jules Bordet Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma21
Prostatic Neoplasms11
Neoplasms5
Disease3
Carcinoma2
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Melanoma2
Pancreatic Neoplasms2
Anus Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.